Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-04-17

FDA Approved: TEMAZEPAM — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved Ascend Laboratories, LLC's supplemental application for Temazepam (generic) under the ANDA pathway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temazepam (Temazepam)

Snippet

SUPPL AP for TEMAZEPAM (TEMAZEPAM)